Association between circulating full-length angiopoietin-like protein 8 and non-high-density lipoprotein cholesterol levels in Chinese non-diabetic individuals: a cross-sectional study

[1] Catapano AL(2011)ESC/EAS guidelines for the management of dyslipidaemias Atherosclerosis 217 3-46

[2] Reiner Ž(2002)(NCEP) expert panel on detection E, and treatment of high blood cholesterol in adults: third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report Circulation 106 3143-3421

[3] De Backer G(2005)Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267-1278

[4] Graham I(2016)2016 ESC/EAS guidelines for the Management of Dyslipidaemias Eur Heart J 37 2999-3058

[5] Taskinen M-R(2016)Chinese guideline for the management of dyslipidemia in adults Zhonghua Xin Xue Guan Bing Za Zhi 2016 833-853

[6] Wiklund O(2007)Insulin resistance, dyslipidemia, and cardiovascular disease Diabetes Care 30 2164-2170

[7] Agewall S(2008)Fatty liver, insulin resistance, and dyslipidemia Curr Diab Rep 8 60-64

[8] Alegria E(2012)Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels Biochem Biophys Res Commun 424 786-792

[9] Chapman MJ(2013)Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis Proc Natl Acad Sci U S A 110 16109-16114

[10] Durrington P(2013)Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci J Med Genet 50 298-308

[1] Catapano AL(2011)ESC/EAS guidelines for the management of dyslipidaemias Atherosclerosis 217 3-46

[2] Reiner Ž(2002)(NCEP) expert panel on detection E, and treatment of high blood cholesterol in adults: third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report Circulation 106 3143-3421

[3] De Backer G(2005)Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267-1278

[4] Graham I(2016)2016 ESC/EAS guidelines for the Management of Dyslipidaemias Eur Heart J 37 2999-3058

[5] Taskinen M-R(2016)Chinese guideline for the management of dyslipidemia in adults Zhonghua Xin Xue Guan Bing Za Zhi 2016 833-853

[6] Wiklund O(2007)Insulin resistance, dyslipidemia, and cardiovascular disease Diabetes Care 30 2164-2170

[7] Agewall S(2008)Fatty liver, insulin resistance, and dyslipidemia Curr Diab Rep 8 60-64

[8] Alegria E(2012)Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels Biochem Biophys Res Commun 424 786-792

[9] Chapman MJ(2013)Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis Proc Natl Acad Sci U S A 110 16109-16114

[10] Durrington P(2013)Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci J Med Genet 50 298-308